Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Indivumed GmbH
company
About
A Hamburg,Germany-based physician-led, integrated global oncology company.
- 101 - 250
Details
- Last Funding Type
- Debt Financing
- Last Funding Money Raised
- €40M
- Industries
- Biotechnology,Clinical Trials,Pharmaceutical
- Founded date
- Jan 1, 2002
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Indivumed was founded in Hamburg, Germany in 2002 with one main driver – the individualization of cancer therapy through the generation, characterization, and analysis of biologic samples from human cancer patients. Since then, the company has expanded globally, with a subsidiary in the USA, partnerships with leading cancer clinics in Europe, the US and Asia and more than 50 oncology practices located in Germany, and, finally, more than 100 biopharma industry partners – and a global reputation for product and service quality.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€40M
Indivumed GmbH has raised a total of
€40M
in funding over 2 rounds. Their latest funding was raised on
Jan 9, 2018 from a Debt Financing round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 9, 2018 | Debt Financing | €40M | 1 |
European Investment Bank
|
— | Detail |
Investments
Number of Investments
Number of Lead Investments
2
0
Indivumed GmbH has made 2 investments. Their most recent investment was on
Oct 18, 2022, when Shardeum raised ₹1.49B.
Investors
Number of Lead Investors
Number of Investors
1
1
Indivumed GmbH is funded by 1 investors.
European Investment Bank
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
European Investment Bank
|
Yes | Debt Financing |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
